Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Moving Pharmacogenetics Into Practice: It’s All About the Evidence!
Jasmine A. Luzum, Natasha Petry, Annette K. Taylor, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 3, pp. 649-661
Open Access | Times Cited: 48

Showing 26-50 of 48 citing articles:

Pharmacogenetics in critical care: association between CYP3A5 rs776746 A/G genotype and acetaminophen response in sepsis and septic shock
C. Scorcella, R. Domizi, Salvatore Amoroso, et al.
BMC Anesthesiology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Congruence Rates for Pharmacogenomic Noninterruptive Alerts
Sarah Mills, Amanda Massmann
Pharmacogenomics (2023) Vol. 24, Iss. 9, pp. 493-500
Closed Access | Times Cited: 3
Evaluation of a Longitudinal Pharmacogenomics Education on Pharmacist Knowledge in a Multicampus Healthcare System
Andrew Lee, Adrian C. Hui, Alexander D. Walker, et al.
Pharmacogenomics (2022) Vol. 23, Iss. 3, pp. 173-182
Closed Access | Times Cited: 5
Genotype and Phenotype Influence the Personal Response to Prostaglandin Analogues and Beta-Blockers in Spanish Glaucoma and Ocular Hypertension Patients
Valeria Opazo-Toro, Virginia Fortuna, Wladimiro Jiménez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2093-2093
Open Access | Times Cited: 2
A review of pharmacogenetic studies in the Bangladeshi population
Md Shaki Mostaid, Md. Abdul Aziz, Jeba Atkia Maisha, et al.
Drug Metabolism and Personalized Therapy (2023) Vol. 38, Iss. 2, pp. 123-131
Closed Access | Times Cited: 2
Temporary Like Achilles: Pre‐emptive germline pharmacogenetic testing
Per Damkier, Michael Asger Andersen
Basic & Clinical Pharmacology & Toxicology (2023) Vol. 133, Iss. 4, pp. 397-399
Closed Access | Times Cited: 2
Progress and Challenges in Pharmacogenomics
Sara L. Van Driest, Ingolf Cascorbi
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 3, pp. 529-532
Open Access | Times Cited: 4
Focus on pharmacogenomics, phytonutrient-drug interactions and COVID-19 vaccines: Perspectives on ADRs, ADEs, and SEDs
Sidhartha D. Ray, Jasmine A. Luzum, Joshua P. Gray, et al.
Side effects of drugs annual (2021), pp. xxv-lii
Open Access | Times Cited: 4
Pediatric considerations for pharmacogenetic selective serotonin reuptake inhibitors clinical decision support
Michelle Liu, Katelyn M. Rossow, Angela Maxwell-Horn, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2022) Vol. 43, Iss. 7, pp. 691-704
Closed Access | Times Cited: 3
Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data Repository
Amy L. Pasternak, Robinson Seda, Joseph Lipa, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 2, pp. 356-361
Open Access | Times Cited: 1
Treatment of Chronic Inflammatory Diseases – The Potential of Pharmacogenetics
Hela Nazari, Vibeke Andersen, Trine Andresen
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Genetic epidemiology in the era of genomic medicine
Siana Nkya
Elsevier eBooks (2024), pp. 207-223
Closed Access
Personalized medicine in old age psychiatry and Alzheimer’s disease
Nikias Siafarikas
Frontiers in Psychiatry (2024) Vol. 15
Open Access
[Artículo traducido] Exploración del impacto de la farmacogenética en la medicina personalizada: una revisión sistemática
Laura Amaro-Álvarez, Jaime Ramos, Miguel Ángel Calleja‐Hernández
Farmacia Hospitalaria (2024)
Open Access
Cardiovascular precision and personalised medicine
Dhavendra Kumar
Elsevier eBooks (2024), pp. 333-350
Closed Access
Considerations in Clinical Laboratory Development of Pharmacogenomic Testing
Stephen J. Wicks, Kristy Crooks
Advances in Molecular Pathology (2024) Vol. 7, Iss. 1, pp. 43-52
Closed Access
Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test
Benoît Delabays, Katerina Trajanoska, Joshua Walonoski, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 791-827
Open Access
A Pharmacogenetic Panel-Based Prediction of the Clinical Outcomes in Elderly Patients with Coronary Artery Disease
Lisha Dong, Shizhao Zhang, Chao Lv, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1079-1079
Open Access
The history and future of pharmacogenetics in Aotearoa/New Zealand
Martin A. Kennedy
Journal of the Royal Society of New Zealand (2024), pp. 1-18
Open Access
A Robust and Fast/Multiplex Pharmacogenetics Assay to Simultaneously Analyze 17 Clinically Relevant Genetic Polymorphisms in CYP3A4, CYP3A5, CYP1A2, CYP2C9, CYP2C19, CYP2D6, ABCB1, and VKORC1 Genes
Camille Tron, Régis Bouvet, Marie‐Clémence Verdier, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 637-637
Open Access | Times Cited: 2
Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
Eric Rytkin, Kseniia Kriukova, Н. П. Денисенко, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access
Pharmacogenomic Precision Medicine: Best Practice Toolkit for Improving Patient Screening for Adult Metastatic Cancer Patients
Rena L. Stewart
(2023)
Open Access
Pharmacogenetics in critical care: the expression of rs776746 polymorphism and acetaminophen response in sepsis and septic shock
C Scorcella, Roberta Domizi, Salvatore Amoroso, et al.
Research Square (Research Square) (2022)
Open Access
Previous Page - Page 2

Scroll to top